BioSpace News Archive

Drug Development

Moderna CEO Says COVID-19 Vaccine Could Get Emergency Approval in December

Stephane Bancel, chief executive officer of Moderna, told analysts and journalists at a Wall Street Journal’s Tech Live event on Monday that the FDA requires enough safety and efficacy data, and he believes that they will have that in the later part of November.

October 21, 2020
·
3 min read
·
Mark Terry
Drug Development

Report: AstraZeneca Could Resume U.S. Arm of COVID-19 Vaccine Study This Week

The U.S. arm of the trial has been paused for more than a month while the U.S. Food and Drug Administration investigates a serious illness that occurred in a patient who received the experimental treatment.

October 21, 2020
·
2 min read
·
Alex Keown
Job Trends

Roche Canada Puts Five-Year Plan into Motion to Create 500 New Jobs in Ontario

Roche Canada is making a $500 million investment to expand its Canadian pharmaceutical headquarters in Ontario, which the company said will bring up to 500 new full-time jobs to the region over the next five years.

October 21, 2020
·
2 min read
·
Brandon May
Despite One Patient Death, CRISPR Therapeutics’ Off-the-Shelf CAR-T Shows Promise

Despite promising Phase I data for its CRISPR-based allogeneic CAR-T therapy, CRISPR Therapeutics may have a safety issue to contend with.

October 21, 2020
·
3 min read
·
Mark Terry
SparingVision Nabs €44.5 Million to Support Gene Therapy, Adds New CEO

Paris-based SparingVision, a genomic medicine company focused on ocular diseases, raised €44.5 million (approximately $52.2 million) in a financing round.

October 21, 2020
·
2 min read
·
Alex Keown
Business

Co-Existing With COVID-19: Containing the Contagion

As we resign ourselves to the fact that the epic SARS-CoV-2 virus that dominated 2020 is going to stubbornly follow us into 2021, we need to learn how to co-exist in temporary tolerance, at least until we have an effective vaccine.

October 21, 2020
·
4 min read
·
Heather McKenzie
BioSpace Global Roundup, Oct. 22

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

October 21, 2020
·
7 min read
·
Alex Keown
How the Biopharma Industry is Tackling the Opioid Crisis

Many drug makers are investing in new science and hope to transition pain therapy approaches away from synthetic opioids. Biospace has tracked a few key alternative therapeutic candidates.

October 21, 2020
·
10 min read
·
Joseph Constance
Business

Daiichi Sankyo Supports Patients and Advocacy Groups for Breast Cancer Awareness Month

October is Breast Cancer Awareness month, and Daiichi Sankyo is aiming to raise awareness about one of the most common forms of cancer across the globe.

October 21, 2020
·
3 min read
·
Alex Keown
Policy

Purdue Pharma Agrees to $8 Billion DOJ Settlement Over Opioid Marketing Practices

The settlement stems from multi-year criminal and civil investigations into Purdue’s marketing practices related to its powerful prescription painkiller, OxyContin, which critics have argued facilitated the opioid epidemic.

October 21, 2020
·
3 min read
·
Brandon May